Actively Recruiting
Evaluation of the Medtronic Implantable Insulin Pump System in Adults with Type 1 Diabetes Unable to Control Blood Sugar with Standard Insulin Therapy
Led by Medtronic MiniMed, Inc. · Updated on 2026-09-22
40
Participants Needed
11
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical performance of the Medtronic Implantable Insulin Pump System MIIPS 2020 in adults with Type 1 diabetes who cannot control their condition with subcutaneous insulin therapy, including external pumps. The study focuses on patients experiencing frequent and unexplained severe episodes of high or low blood sugar. This is a premarket, interventional, prospective, open-label, multi-center study aiming to assess this new implantable device. The study includes a run-in period to collect baseline glucose data while participants use their current therapy. During the 6-month study period, participants will have the MIIPS 2020 implanted and receive insulin through intraperitoneal infusion. After completing the main study, participants may continue using the investigational device in a continued access period until it gains commercial approval, after which they will keep wearing the implanted pump. Participants will be monitored through assessments including refill accuracy of the implantable pump over six months. Data collection includes baseline continuous glucose monitoring, follow-up refill visits, and tracking of pump accuracy and maintenance needs. Safety and treatment adherence will be observed throughout the study and continued access period, which lasts until the device achieves regulatory approval, with the trial expected to complete by September 2027.
CONDITIONS
Brief Title
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
Research Team
L
Laura Fusco
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here